Screener
Bionano Genomics, Inc. BNGO Q4 2025 Annual earnings
Reported March 23, 2026 · After market close
Revenue$8.0MBeat by $71.5K
EPS-$0.03Beat by $0.78
Revenue estimate$7.9M
EPS estimate-$0.81
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$8.4M
EPS estimate-$0.45
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Bionano Genomics, Inc. report Q4 2025 earnings?
- Bionano Genomics, Inc. (BNGO) reported Q4 2025 earnings on March 23, 2026 after market close.
- What were Bionano Genomics, Inc.'s Q4 2025 revenue and EPS?
- Bionano Genomics, Inc. reported revenue of $8.0M and eps of $-0.03 for Q4 2025.
- Did Bionano Genomics, Inc. beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $7.9M by $71.5K. EPS beat the consensus estimate of $-0.81 by $0.78.
- How did Bionano Genomics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 2.6% from $8.2M a year earlier and eps grew 99.9% from $-57.49.
- Where can I find Bionano Genomics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001411690-26-000006) and the 10-K periodic report (0001411690-26-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.
